D. Mitchell

发表

Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.

I. Bernstein, J. Eary, R. Storb, 1999, Blood.

Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.

S. A. Bush, J. Eary, F. Appelbaum, 1995, Blood.

Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells.

A. Richter, J. Levy, T. Igarashi, 1993, Blood.

Dye-mediated photolysis is capable of eliminating drug-resistant (MDR+) tumor cells

A. Richter, J. Levy, T. Igarashi, 1993 .

Phase I study of 131I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome

I. Bernstein, J. Eary, R. Storb, 1999 .

Relative sensitivity of leukemic (CML) and normal progenitor cells to treatment with the photosensitizer benzoporphyrin derivative and light.

A. Hornby, A. Richter, J. Levy, 1993, Journal of hematotherapy.

I-Anti-CD 45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome

I. Bernstein, J. Eary, R. Storb, 1999 .

“Superhumanized” Antibodies: Reduction of Immunogenic Potential by Complementarity-Determining Region Grafting with Human Germline Sequences: Application to an Anti-CD281

M. Holmes, J. Foote, C. Anasetti, 2002, The Journal of Immunology.